Highbridge Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
2017
Q1
$701K Buy
2016
Q4
$470K Buy
2016
Q3
$545K Sell
2016
Q2
$3.66M Buy
2015
Q1
Sell
2014
Q4
$230K Buy
2013
Q4
Sell
2013
Q3
$24.3M Buy
2013
Q2
$20.2M Buy